CVS Profits Eclipse $2.2 Billion As Company Integrates New Healthcare Businesses

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 59%

Business News News

Business Business Latest News,Business Business Headlines

I've written about health care for three decades, starting from my native Iowa where I covered the presidential campaign bus rides of Bill and Hillary Clinton through the Hawkeye state talking health reform and the economy.

growth across all the company’s businesses and contributions from its new healthcare services acquisitions, the company said Nov. 1, 2023. In this photo, a pedestrian walks into a CVS Pharmacy in Washington, DC, on November 2, 2022. CVS Health reported net income of $2.2 billion thanks to double-digit percentage sales growth across all the company’s businesses and contributions from its new healthcare services acquisitions.

The company reported net income of $2.27 billion, or $1.75 per share, for the third quarter compared to a net loss of $3.40 billion, or $2.59 per share, in the year ago quarter when the company recorded $5 billion in opioid-related litigation charges. In its health care services business, which includes Oak Street and Signify, total revenues increased 8.4% to $46.9 billion “primarily driven by pharmacy drug mix, growth in specialty pharmacy, brand inflation and the acquisitions of Oak Street Health and Signify Health.” Operating income jumped nearly 11% to $1.9 billion in CVS; healthcare services segment.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 318. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CVS Earnings Top Estimates but Stock Drops as Outlook Is Slashed AgainCVS revises lower its guidance range for diluted GAAP earnings per share for the third straight quarter.
Source: MarketWatch - 🏆 3. / 97 Read more »

CVS Health’s stock up after earnings beat, but company lowers full-year EPS guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »